New book on RNA therapeutics edited by Mouldy Sioud: From siRNA to mRNA Innovations Highlights the Future of RNA Medicine
"RNA Therapeutics: From siRNA to mRNA Innovations", edited by Mouldy Sioud and published by Springer Nature, presents a comprehensive and authoritative overview of the scientific advances driving the rapid growth of RNA-based therapeutics. This landmark volume brings together leading international experts to explore the evolution of RNA technologies and their expanding role in modern medicine.
Mouldy Sioud leads the Immunomodulation and Targeted Therapies research group at the Department of Cancer Immunology at the Institute for Cancer Research.
Covering topics from fundamental molecular mechanisms to clinical translation and commercial development, the book examines major breakthroughs in siRNA, mRNA, RNA delivery systems, and emerging therapeutic platforms. As RNA technologies continue to revolutionize vaccine development, genetic disease treatment, oncology, and infectious disease management, this publication offers critical insights into both current applications and future opportunities.
Designed as a definitive reference, the volume serves researchers, clinicians, biotechnology professionals, and graduate students working at the forefront of biomedical innovation.
Links:
RNA Therapeutics - From siRNA to mRNA Innovations (springer.com)
The Immunomodulation and Targeted Therapies research group, headed by Mouldy Sioud
The Department of Cancer Immunology